Nutrition and Neurodegeneration: Epidemiological Evidence and Challenges for Future Research

Overview

Journal Br J Clin Pharmacol

Specialty Pharmacology

Date 2013 Feb 7

PMID 23384081

Citations 63

Authors

Sophie Gillette-Guyonnet

Marion Secher

Bruno Vellas

Affiliations

Soon will be listed here.

Abstract

The prevention of dementias, such as Alzheimer's disease (AD), is a growing public health concern, due to a lack of effective curative treatment options and a rising global prevalence. Various potential risk or preventive factors have been suggested by epidemiological research, including modifiable lifestyle factors such as diet. Current epidemiological data are in favour of a protective role of certain micronutrients (B vitamins related to homocysteine metabolism, the anti-oxidant vitamins C and E, flavonoids, polyunsatured omega-3 fatty acids, vitamin D) and macronutrients (fish) in the prevention of cognitive decline and dementia/AD. Some factors have been targeted by interventions tested in randomized controlled trials (RCTs), but many of the results are conflicting with observational evidence. Epidemiological analysis of the relations between nutrient consumption and cognitive decline is complex and it is highly unlikely that a single component plays a major role. In addition, since multiple factors across the life course influence brain function in late life, multidomain interventions might be more promising in the prevention of cognitive decline and dementia/AD. Designing such trials remains very challenging for researchers. The main objective of this paper is to review the epidemiologic data linking potential protective factors to cognitive decline or dementia/AD, focusing particularly on the roles of adiposity, caloric restriction, micro (group B vitamins related to homocysteine metabolism, the anti-oxidant vitamins C and E, flavonoids, polyunsatured omega-3 fatty acids, vitamin D) and macronutrients (fish). Limitations of the current data, divergence with results of interventional prevention studies and challenges for future research are discussed.

Citing Articles

Exploring nutraceutical approaches linking metabolic syndrome and cognitive impairment.

Sonnino R, Ciccarelli G, Moffa S, Soldovieri L, Giuseppe G, Brunetti M iScience. 2025; 28(2):111848.

PMID: 40008362 PMC: 11850164. DOI: 10.1016/j.isci.2025.111848.

Glucose enrichment reduces lifespan and promotes tau phosphorylation in human tau-expressing C. elegans, unaffected by O-β-GlcNAcylation induction.

Ahmad W, Shabbiri K J Mol Med (Berl). 2025; 103(3):327-338.

PMID: 39924618 DOI: 10.1007/s00109-025-02522-3.

Neuroprotective Effects of Myrtle Berry By-Product Extracts on 6-OHDA-Induced Cytotoxicity in PC12 Cells.

Dessi D, Fais G, Follesa P, Sarais G Antioxidants (Basel). 2025; 14(1).

PMID: 39857422 PMC: 11759165. DOI: 10.3390/antiox14010088.

Perceptions and practices of imaging personnel and physicians regarding the use of brain MRI for dementia diagnosis in Uganda.

Nassanga R, Nakasujja N, Kaddumukasa M, Jones S, Sajatovic M, Kawooya M PLoS One. 2025; 20(1):e0305788.

PMID: 39823447 PMC: 11741567. DOI: 10.1371/journal.pone.0305788.

The Association Between Intermittent Fasting and Glaucoma.

Schulz M, Ding L, Feng S, Chen A, Chen P, Bojikian K J Glaucoma. 2024; 34(1):1-6.

PMID: 39445885 PMC: 11634075. DOI: 10.1097/IJG.0000000000002515.

References

Gillette-Guyonnet S, Andrieu S, Dantoine T, Dartigues J, Touchon J, Vellas B . Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease. Alzheimers Dement. 2009; 5(2):114-21. DOI: 10.1016/j.jalz.2009.01.008. View

Rovio S, Kareholt I, Helkala E, Viitanen M, Winblad B, Tuomilehto J . Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol. 2005; 4(11):705-11. DOI: 10.1016/S1474-4422(05)70198-8. View

Barberger-Gateau P, Samieri C, Feart C, Plourde M . Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype. Curr Alzheimer Res. 2011; 8(5):479-91. PMC: 3518784. DOI: 10.2174/156720511796391926. View

Devore E, Grodstein F, van Rooij F, Hofman A, Stampfer M, Witteman J . Dietary antioxidants and long-term risk of dementia. Arch Neurol. 2010; 67(7):819-25. PMC: 2923546. DOI: 10.1001/archneurol.2010.144. View

Geleijnse J, Giltay E, Kromhout D . Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients. Alzheimers Dement. 2011; 8(4):278-87. DOI: 10.1016/j.jalz.2011.06.002. View

Lin P, Appel L, Funk K, Craddick S, Chen C, Elmer P . The PREMIER intervention helps participants follow the Dietary Approaches to Stop Hypertension dietary pattern and the current Dietary Reference Intakes recommendations. J Am Diet Assoc. 2007; 107(9):1541-51. DOI: 10.1016/j.jada.2007.06.019. View

Balion C, Griffith L, Strifler L, Henderson M, Patterson C, Heckman G . Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology. 2012; 79(13):1397-405. PMC: 3448747. DOI: 10.1212/WNL.0b013e31826c197f. View

Varela S, Ayan C, Cancela J, Martin V . Effects of two different intensities of aerobic exercise on elderly people with mild cognitive impairment: a randomized pilot study. Clin Rehabil. 2011; 26(5):442-50. DOI: 10.1177/0269215511425835. View

Kalmijn S, van Boxtel M, Ocke M, Verschuren W, Kromhout D, Launer L . Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology. 2004; 62(2):275-80. DOI: 10.1212/01.wnl.0000103860.75218.a5. View

10.

Sturman M, Mendes de Leon C, Bienias J, Morris M, Wilson R, Evans D . Body mass index and cognitive decline in a biracial community population. Neurology. 2007; 70(5):360-7. DOI: 10.1212/01.wnl.0000285081.04409.bb. View

11.

Weuve J, Kang J, Manson J, Breteler M, Ware J, Grodstein F . Physical activity, including walking, and cognitive function in older women. JAMA. 2004; 292(12):1454-61. DOI: 10.1001/jama.292.12.1454. View

12.

Luchsinger J, Tang M, Miller J, Green R, Mayeux R . Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol. 2007; 64(1):86-92. DOI: 10.1001/archneur.64.1.86. View

13.

Gustafson D, Backman K, Waern M, Ostling S, Guo X, Zandi P . Adiposity indicators and dementia over 32 years in Sweden. Neurology. 2009; 73(19):1559-66. PMC: 2777073. DOI: 10.1212/WNL.0b013e3181c0d4b6. View

14.

Lautenschlager N, Cox K, Flicker L, Foster J, Bockxmeer F, Xiao J . Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA. 2008; 300(9):1027-37. DOI: 10.1001/jama.300.9.1027. View

15.

Liang K, Mintun M, Fagan A, Goate A, Bugg J, Holtzman D . Exercise and Alzheimer's disease biomarkers in cognitively normal older adults. Ann Neurol. 2010; 68(3):311-8. PMC: 2936720. DOI: 10.1002/ana.22096. View

16.

Abbott R, White L, Ross G, Masaki K, Curb J, Petrovitch H . Walking and dementia in physically capable elderly men. JAMA. 2004; 292(12):1447-53. DOI: 10.1001/jama.292.12.1447. View

17.

Fratiglioni L, Winblad B, von Strauss E . Prevention of Alzheimer's disease and dementia. Major findings from the Kungsholmen Project. Physiol Behav. 2007; 92(1-2):98-104. DOI: 10.1016/j.physbeh.2007.05.059. View

18.

Engelhart M, Geerlings M, Ruitenberg A, Van Swieten J, Hofman A, Witteman J . Dietary intake of antioxidants and risk of Alzheimer disease. JAMA. 2002; 287(24):3223-9. DOI: 10.1001/jama.287.24.3223. View

19.

Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B . Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol. 2005; 62(10):1556-60. DOI: 10.1001/archneur.62.10.1556. View

20.

Scarmeas N, Stern Y, Mayeux R, Manly J, Schupf N, Luchsinger J . Mediterranean diet and mild cognitive impairment. Arch Neurol. 2009; 66(2):216-25. PMC: 2653223. DOI: 10.1001/archneurol.2008.536. View